Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneous coronary intervention: meta-analysis of randomised controlled trials
Conclusionour meta-analysis suggests that short DAPT may be a valid option in older patients after PCI but it also highlights the need for specific studies in such patients on optimal duration of antiplatelet therapy.
Source: Age and Ageing - Category: Geriatrics Source Type: research
More News: Angioplasty | Bleeding | Coronary Angioplasty | Geriatrics | Percutaneous Coronary Intervention | Study